ECM Weekly (31 May 2020) - JD & NetEase HK, Legend Biotech, Burning Rock, Dada Nexus, Kangji
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As per...
321 Views
Legend Biotech (传奇生物) Pre-IPO: Superior Efficacy Vs Bluebird/BMS Candidate
Legend Biotech, a subsidiary of Hong Kong-listed GenScript, is planning to raise up to USD 300 million via an IPO. The company has a strong focus...
323 Views
ECM Weekly (24 May 2020) - NetEase and JD Homecoming, Legend Biotech, Nongfu Spring, Yeahka
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The talk...
215 Views
Legend Biotech (传奇生物) Pre-IPO: All-Stars Except for the Small Indication
Legend Biotech, a subsidiary of Hong Kong-listed GenScript, is planning to raise up to USD 300 million via an IPO. The company has a strong focus...
198 Views
Legend Biotech IPO Initiation: Choosing Therapies À La CAR-T
Legend Biotech (BLG US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
150 Views